Omega 3: Clinical Trials

8 trials of Omega 3, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 2 unknown. 8 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 38Completed 6, Unknown 2
Phase 22Completed 2

Follow Omega 3: new trials by email Literature Review of Omega 3 trials Research Report on Omega 3

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Hydroxy Urea, Omega 3, Nigella Sativa,Honey on Oxidative Stress and Iron Chelation in Pediatric Major Thalassemia
Omega 3, Nigella Sativa Oil, Hydroxyurea - Iron Overload, Oxidative Stress
Phase 2 / Phase 3CompletedBeni-Suef University3502019-11-012021-01-27
Different Treatment Modalities in the Management of the Painful Crisis in Pediatric Sickle- Cell Anemia
Omega 3, Vit D, Zinc sulfate - Vaso-occlusive Crisis, Sickle Cell Disease
Phase 2 / Phase 3CompletedBeni-Suef University3502019-11-012021-01-27
A Two Comparator, Controlled Phase 3 Study in Patients With and Without Evaporative Dry Eye
Omega 3, Optive Advanced, Optive - Dry Eye Syndromes
Phase 3CompletedThe University of New South Wales402016-09-192020-05-12
Studying the Effects of Administration of Polyunsaturated Fatty Acids (PUFAS) of Omega-3 Series in Nicotine Dependence
Omega 3, Placebo - Tobacco Dependence, Nicotine Dependence
Phase 3CompletedFederal University of São Paulo582013-01-012020-10-14
Does Omega-3 Polyunsaturated Fatty Acids (PUFAs) Pretreatment Improve Outcomes in Patients Undergoing Percutaneous Coronary Intervention (PCI)?
omega 3 - Coronary Arteriosclerosis
Phase 3UnknownShiraz University of Medical Sciences902012-02-012013-01-29
Study of the Effect of omega3 on Biomarkers of Cardiac Necrosis (CKMB and Troponin I) and Inflammation Marker (CRP) After Elective Percutaneous Coronary Intervention (PCI)
omega 3 - Coronary Arteriosclerosis
Phase 3CompletedShahid Beheshti University of Medical Sciences1042012-01-012012-12-10
Potential Effects of Omega 3 Supplementation on Cardiomyocytes Membranes for Patients With Coronary Atherosclerosis?
Omega 3 - Coronary Atherosclerosis
Phase 3UnknownUniversity Hospital, Clermont-Ferrand302011-03-012012-10-03
Omega 3 Supplementation in Fatty Liver
Omega 3 - Fatty Liver
Phase 3CompletedUniversity of Sao Paulo General Hospital602009-09-012013-11-25

Conditions studied

Coronary Artery Disease (3)  ·  Anemia, Sickle Cell (1)  ·  Dry Eye Syndromes (1)  ·  Fatty Liver (1)  ·  Iron Overload (1)  ·  Non-alcoholic Fatty Liver Disease (1)  ·  Tobacco Use Disorder (1)  ·  Vaso-Occlusive Crises (1)  ·  beta-Thalassemia (1)

Sponsors

Beni-Suef University (2)  ·  Federal University of São Paulo (1)  ·  Shahid Beheshti University of Medical Sciences (1)  ·  Shiraz University of Medical Sciences (1)  ·  The University of New South Wales (1)  ·  University Hospital, Clermont-Ferrand (1)  ·  University of Sao Paulo General Hospital (1)

Countries

Brazil (2)  ·  Egypt (2)  ·  Iran (2)  ·  Saudi Arabia (2)  ·  France (1)

Top investigators

Ahmed F Mahmoud Hussein, MS.c (2)  ·  Fiona Stapleton, PhD (1)  ·  Jamshid Salamzadeh, PhD (1)

Results publications

PMID 23134549